Hemophilus influenzae infections: a brief review.
Invasive disease due to Hemophilus influenzae constitutes a major pediatric problem. The present article summarizes current concepts regarding epidemiologic, diagnostic, preventive and therapeutic aspects of Hemophilus influenzae infections.
D000667:Ampicillin / Q000627:therapeutic use; D000942:Antigens, Bacterial / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D006192:Haemophilus Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D006193:Haemophilus influenzae / Q000276:immunology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008583:Meningitis, Haemophilus / Q000453:epidemiology; D010400:Penicillin G / Q000627:therapeutic use; D010403:Penicillin Resistance; D013307:Streptomycin / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D014611:Vaccination
D000942:Antigens, Bacterial; D002701:Chloramphenicol; D000667:Ampicillin; D014295:Trimethoprim; D013752:Tetracycline; D013420:Sulfamethoxazole; D010400:Penicillin G; D013307:Streptomycin